Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Drappatz

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Continuum (Minneapolis, Minn.)|July 20, 2012
Medical care of patients with brain tumorsJan Drappatz
Expert Opinion on Pharmacotherapy|October 3, 2022
How useful is chemotherapy for atypical and anaplastic meningiomas?Jan Drappatz
Expert Review of Neurotherapeutics|September 11, 2023
Advances in the systemic therapy for recurrent meningiomas and the challenges aheadYi Li, Jan Drappatz
Clinical Lymphoma|January 8, 2005
Neurologic complications of plasma cell disordersJan Drappatz, Tracy Batchelor
Progress in Neurological Surgery|February 3, 2018
Chemotherapy of OligodendrogliomasJan Drappatz, Frank Lieberman
Journal of Neuro-Oncology|March 18, 2022
Immune checkpoint inhibitor therapy for recurrent meningiomas: a retrospective chart reviewPriya Nidamanuri, Jan Drappatz
Frontiers in Oncology|March 6, 2023
Immunotherapy associated central nervous system complications in primary brain tumorsMegan Mantica, Jan Drappatz
Journal of Neuro-Oncology|December 11, 2025
Treatment strategies and innovation for recurrent high-grade gliomaJan Drappatz, Megan Mantica
Current Treatment Options in Neurology|June 21, 2007
Leptomeningeal neoplasmsJan Drappatz, Tracy T Batchelor
Current Opinion in Neurology|November 16, 2004
Non-cytotoxic drugs as potential treatments for gliomasJan Drappatz, Patrick Y Wen
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Continuum (Minneapolis, Minn.)|July 20, 2012
Medical care of patients with brain tumorsJan Drappatz
Expert Opinion on Pharmacotherapy|October 3, 2022
How useful is chemotherapy for atypical and anaplastic meningiomas?Jan Drappatz
Expert Review of Neurotherapeutics|September 11, 2023
Advances in the systemic therapy for recurrent meningiomas and the challenges aheadYi Li, Jan Drappatz
Clinical Lymphoma|January 8, 2005
Neurologic complications of plasma cell disordersJan Drappatz, Tracy Batchelor
Progress in Neurological Surgery|February 3, 2018
Chemotherapy of OligodendrogliomasJan Drappatz, Frank Lieberman
Journal of Neuro-Oncology|March 18, 2022
Immune checkpoint inhibitor therapy for recurrent meningiomas: a retrospective chart reviewPriya Nidamanuri, Jan Drappatz
Frontiers in Oncology|March 6, 2023
Immunotherapy associated central nervous system complications in primary brain tumorsMegan Mantica, Jan Drappatz
Journal of Neuro-Oncology|December 11, 2025
Treatment strategies and innovation for recurrent high-grade gliomaJan Drappatz, Megan Mantica
Current Treatment Options in Neurology|June 21, 2007
Leptomeningeal neoplasmsJan Drappatz, Tracy T Batchelor
Current Opinion in Neurology|November 16, 2004
Non-cytotoxic drugs as potential treatments for gliomasJan Drappatz, Patrick Y Wen
Pageof 13